<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: N (1) ,N (12)-Diacetylspermine (DiAcSpm) is a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> marker featured by increase in the urine of patients with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>, including early <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, but where and how DiAcSpm is made remains unclear </plain></SENT>
<SENT sid="1" pm="."><plain>We aimed to clarify whether <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> tissues produce increased amounts of DiAcSpm, and if they do, to examine whether tissue DiAcSpm level may serve as a criterion of tissue <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Tissue samples were obtained from 140 patients (13 low-grade intraepithelial <z:hpo ids='HP_0002664'>neoplasia</z:hpo>, 98 high-grade intraepithelial <z:hpo ids='HP_0002664'>neoplasia</z:hpo> and 29 colorectal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>) treated for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> and intraepithelial <z:hpo ids='HP_0002664'>neoplasia</z:hpo> at Tokyo Metropolitan Komagome Hospital between November 2007 and April 2011 </plain></SENT>
<SENT sid="3" pm="."><plain>The DiAcSpm level in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> and adjacent <z:mpath ids='MPATH_458'>normal</z:mpath> tissue extracts was compared, and its relationship with clinical stages of the diseases was analyzed </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: DiAcSpm levels were higher in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> tissue (p &lt; 0.01, n = 12) and its <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> (p &lt; 0.05, n = 5) than in adjacent <z:mpath ids='MPATH_458'>normal</z:mpath> tissues </plain></SENT>
<SENT sid="5" pm="."><plain>The <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>/<z:mpath ids='MPATH_458'>normal</z:mpath> ratio of tissue DiAcSpm content was examined for endoscopically obtained <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> and adjacent <z:mpath ids='MPATH_458'>normal</z:mpath> tissues from patients with intraepithelial <z:hpo ids='HP_0002664'>neoplasia</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>The ratio was greater than 1.5 in 38 % (5/13) and 78 % (84/108) of low-grade intraepithelial <z:hpo ids='HP_0002664'>neoplasia</z:hpo> and high-grade intraepithelial <z:hpo ids='HP_0002664'>neoplasia</z:hpo>, respectively </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: Tissue DiAcSpm levels increase in the tissue of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> and also in precancerous lesion, such as high-grade intraepithelial <z:hpo ids='HP_0002664'>neoplasia</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>The increase is considered a sign that a tissue is acquiring malignant characteristics </plain></SENT>
<SENT sid="9" pm="."><plain>It is likely that the DiAcSpm produced by <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells is responsible for the frequent increase in urinary DiAcSpm in early <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients </plain></SENT>
</text></document>